- MESOX was awarded the National Start-Up Award from Medilink UK
- A spin-out from Aston Pharmacy School, MESOX develops drug carrier technology to improve medicine formulations
- The company won the Start-Up prize at the Medilink Midlands Awards 2024 and went on the national competition.
A spin-out company from Aston University’s pharmaceutics research group, MESOX, has won a major national medical technology and life sciences industry award.
MESOX, which was founded by Aston University pharmaceutics lecturer Dr Ali Al-Khattawi, has been awarded the National Start-Up Award from Medilink UK. The awards recognise outstanding contributions to medtech life sciences.
With in-depth expertise in particle engineering for drug delivery and pharmaceutical spray drying, MESOX uses IP-protected carriers to improve the bioavailability and efficacy of pharmaceuticals, partnering with pharmaceutical and biotechnology companies to bring challenging therapeutics to market.
MESOX won the Medilink Midlands Start-Up Award in May 2024, which is presented to a newly established company that shows a promising future. As a result of the win, MESOX went on to compete in the national awards against the other regional winners. The independent judging panel, representing key stakeholders in life sciences, assessed entrants in each of the seven categories on the merit of their contribution to the improvement of patient care.
The award was presented by Kevin Kiely MBE, executive chairman, Medilink North of England and Bill Cruise, chairman of Medilink UK, at a ceremony at the London Institute for Healthcare Engineering (LIHE), held on 11 July 2024.
Dr Al-Khattawi said:
“This is a proud moment for the MESOX team and a testament to the potential of our company. To be selected from among hundreds of great life science start-ups in the UK is a great privilege. This highlights the transformative potential of our company in advancing the formulation development of innovative therapeutics.”
Bill Cruise said:
“The Medilink UK Awards have once again been a tremendous success, and I offer my congratulations to all the award winners and finalists. Now, more than ever, we need the groundbreaking contributions of these and the many other companies across the Life Sciences sector to improve patient outcomes and provide efficiency.
“As a national industry support organisation, Medilink UK is pleased to work with our companies, adding value by helping them, and the Life Sciences sector as a whole, to grow, both nationally and internationally. We are proud to be contributing to their success, and I am confident that each of the companies who are here today will go on to do amazing things”.
- Notes to editors
About Aston University
For over a century, Aston University’s enduring purpose has been to make our world a better place through education, research and innovation, by enabling our students to succeed in work and life, and by supporting our communities to thrive economically, socially and culturally.
Aston University’s history has been intertwined with the history of Birmingham, a remarkable city that once was the heartland of the Industrial Revolution and the manufacturing powerhouse of the world.
Born out of the First Industrial Revolution, Aston University has a proud and distinct heritage dating back to our formation as the School of Metallurgy in 1875, the first UK College of Technology in 1951, gaining university status by Royal Charter in 1966, and becoming the Guardian University of the Year in 2020.
Building on our outstanding past, we are now defining our place and role in the Fourth Industrial Revolution (and beyond) within a rapidly changing world.
For media inquiries in relation to this release, contact Helen Tunnicliffe, Press and Communications Manager, on (+44) 7827 090240 or email: h.tunnicliffe@aston.ac.uk.
Be first to get the latest news, research and expert comment from Aston by following us on X.
Need an expert for your story? Browse our experts directory.